ArticleiScience2026

Covalent Bruton's tyrosine kinase inhibitor HZ-A-018 in patients with relapsed or refractory B cell malignancies: A multicenter phase I study.

Guolan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.